AdaptHealth COO granted 20,134 RSUs in Form 4

AdaptHealth Corp. reported that Chief Operating Officer Daniel Edward McFadden received an equity award in the form of restricted stock units.

Rhea-AI Filing Summary

AdaptHealth Corp. reported that Chief Operating Officer Daniel Edward McFadden received an equity award in the form of restricted stock units. On the transaction date, he acquired 20,134 shares of Common Stock at no cash cost as a grant, increasing his direct holdings to 103,376 shares after the award. The footnote explains that these shares are restricted stock units that will be settled in common stock when they vest, meaning he does not receive all shares immediately but over time as vesting conditions are met.

Insider Trade Summary

Grant/Award: 20,134 shares

Grant/Award 1 txn

Insider McFadden Daniel Edward

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,134	$0.00	$0.00

Holdings After Transaction: Common Stock — 103,376 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Key Figures

RSU grant size: 20,134 shares Grant price per share: $0.00 per share Shares after transaction: 103,376 shares +3 more

6 metrics

RSU grant size 20,134 shares Restricted stock units granted on 2026-05-27

Grant price per share $0.00 per share Equity award, non-cash compensation

Shares after transaction 103,376 shares Total direct holdings following the grant

Buy transactions 0 No open-market purchases reported in this Form 4

Sell transactions 0 No open-market sales reported in this Form 4

Acquire transactions 1 One grant/award acquisition of common stock

Key Terms

restricted stock units, Common Stock, Grant, award, or other acquisition, Chief Operating Officer

4 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Chief Operating Officer financial

"officer_title: "Chief Operating Officer""

A chief operating officer (COO) is a senior executive responsible for overseeing the day-to-day activities of a company, ensuring that all parts of the organization work smoothly and efficiently. They often act like a company's operational quarterback, translating strategic plans into practical actions. For investors, the COO's effectiveness can influence a company's performance and stability, making them an important figure in assessing the company's management strength.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Daniel Edward McFadden?

AdaptHealth reported that Chief Operating Officer Daniel Edward McFadden received a grant of 20,134 restricted stock units. These units represent a compensation award and will convert into common stock upon vesting, rather than an open-market share purchase.

How many AdaptHealth (AHCO) shares does Daniel Edward McFadden hold after this Form 4?

After the reported grant, Daniel Edward McFadden holds 103,376 shares of AdaptHealth common stock directly. This total includes the 20,134 restricted stock units awarded, which will be settled in common stock when the units vest under the award terms.

Was the AdaptHealth (AHCO) Form 4 transaction a market purchase or sale?

The Form 4 transaction was not a market purchase or sale. It reflects a grant or award acquisition of 20,134 restricted stock units at a price of $0.00 per share, issued as equity compensation rather than bought or sold on the open market.

What does it mean that AdaptHealth (AHCO) granted restricted stock units to its COO?

Granting restricted stock units means AdaptHealth awarded the COO a right to receive 20,134 shares of common stock in the future. These units typically vest over time or upon conditions, aligning executive compensation with company performance and long-term shareholder interests.

Does the AdaptHealth (AHCO) Form 4 indicate any derivative securities for the COO?

The Form 4 data show no derivative securities for the COO in this filing. The derivativeSummary is empty, and the only reported transaction is a non-derivative grant of restricted stock units that will convert into common stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McFadden Daniel Edward

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		A		20,134(1)	A	$0	103,376	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 26, 2025 as an exhibit to the Form 3 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Daniel McFadden	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)